临床肿瘤学杂志

[1]August DA,Huhmann MB.A.S.P.E.N.clinical guidelines:nu-trition support therapy during adult anticancer treatment and inhematopoietic cell transplantation[J].JPEN J Parenter EnteralNutr,2009,33(5):472-500.

[2]Bozzetti F,Arends J,Lundholm K,et al.ESPEN Guidelines onParenteral Nutrition:non-surgical oncology[J].Clin Nutr,2009,28(4):445-454.

[3]Braga M,Ljungqvist O,Soeters P,et al.ESPEN Guidelines onParenteral Nutrition:surgery[J].Clin Nutr,2009,28(4):378-386.

[4]Weimann A,Braga M,Harsanyi L,et al.ESPEN guidelines onenteral nutrition:Surgery including organ transplantation[J].ClinNutr,2006,25(2):224-244.

[5]Arends J,Bodoky G,Bozzetti F,et al.ESPEN guidelines on en-teral nutrition:Non-surgical oncology[J].Clin Nutr,2006,25(2):245-259.

[6]Fearon K,Strasser F,Anker SD,et al.Definition and classifica-tion of cancer cachexia:an international consensus[J].LancetOncol,2011,12(5):489-495.

[7]Detsky AS,McLaughlin JR,Baker JP,et al.What is subjectiveglobal assessment of nutritional status?[J].J Parenter EnteralNutr,1987,11(2):8-13.

[8]Guigoz Y.The mini nutritional assessment(MNA)review of theliterature-What does it tell us?[J].J Nutr Health Aging,2006,10(6):466-485.

[9]Stratton RJ,King CL,Stroud MA,et al.Malnutrition universalscreening tool predicts mortality and length of hospital stay in a-cutely ill elderly[J].Br J Nutr,2006,95(15):325-330.

[10]Kondrup J,Rasmussen HH,Hamberg O,et al.Nutritional riskscreening(NRS2002):a new method based on an analysis of con-trolled clinical trials[J].Clin Nutr,2003,22(3):321-336.

[11]Kondrup J,Allison P,Elia M.ESPEN guidelines for nutritionscreening 2002[J].Clin Nutr,2003,22(5):415-417.

[12]中华医学会.临床诊疗指南:肠内肠外营养学分册[M].北京:人民卫生出版社,2006:15-19.

[13]Liang X,Jiang ZM,Nolan MT,et al.Comparative survey on nu-tritional risk and nutritional support between Beijing and Baltimoreteaching hospitals[J].Nutrition,2008,24(10):969-976.

[14]于康,夏莹,王孟昭,等.营养风险筛查和主观全面评定用于肺癌非手术患者营养筛查的比较[J].中国临床营养杂志,2008,16(4):349-351.

[15]陈伟,蒋朱明,张咏梅,等.欧洲营养风险调查方法在中国住院患者的临床可行性研究[J].中国临床营养杂志,2005,13(3):137-141.

[16]Jiang ZM,Chen W,Zhan WH,et al.Parenteral and enteral nutri-tion application in west,middle and east China:a multicenter in-vestigation for 15098 patients in 13 metropolitans using nutritionalrisk screening 2002 tool[J].Clin Nutr Suppl,2007,2(2):133-134.

[17]Heyland DK,Montalvo M,MacDonald S,et al.Total parenteralnutrition in the surgical patient:a meta-analysis[J].Can J Surg,2001,44(2):102-111.

[18]Braga M,Gianotti L,Gentilini O,et al.Feeding the gut early af-ter digestive surgery:results of a nine-year experience[J].ClinNutr,2002,21(1):59-65.

[19]Spies CD,Breuer JP,Gust R,et al.Preoperative fasting,an up-date[J].Anaesthesist,2003,52(11):1039-1045.

[20]Soop M,Nygren J,Thorell A,et al.Preoperative oral carbohy-drate treatment attenuates endogenous glucose release 3 days aftersurgery[J].Clin Nutr,2004,23(4):733-741.

[21]Henriksen MG,Hessov I,Dela F,et al.Effects of preoperative o-ral carbohydrates and peptides on postoperative endocrine re-sponse,mobilization,nutrition and muscle function in abdominalsurgery[J].Acta Anaesthesiol Scand,2003,47(2):191-199.

[22]Breuer JP,von Dossow V,von Heymann C,et al.Preoperative o-ral carbohydrate administration to ASA III-IV patients undergoingelective cardiac surgery[J].Anesth Analg,2006,103(5):1099-1108.

[23]Feo CV,Romanini B,Sortini D,et al.Early oral feeding aftercolorectal resection:a randomized controlled study[J].ANZ JSurg,2004,74(5):298-301.

[24]Nirula R,Yamada K,Waxman K.The effect of abrupt cessation oftotal parenteral nutrition on serum glucose:a randomized trial[J].Am Surg,2000,66(9):866-869.

[25]Chin TY,Hu WY,Chuang RB,et a1.Terminal cancer patients'wishes and influencing factors toward the provision of artificial nu-trition and hydration in Taiwan[J].J Pain Symptom Manage,2004,27(3):206-214.

[26]Ulander K,Jeppsson B,Grahn G.Postoperative energy intake inpatients after colorectal cancer surgery[J].Scand J Caring Sci,1998,12(3):131-138.

[27]Correia MI,Caiaffa WT,da Silva AL,et al.Risk factors for mal-nutrition in patients undergoing gastroenterological and hernia sur-gery:an analysis of 374 patients[J].Nutr Hosp,2001,16(2):59-64.

[28]The Veterans Affairs Total Parenteral Nutrition Cooperative StudyGroup.Perioperative total parenteral nutrition in surgical patients[J].N Engl J Med,1991,325(8):525-532.

[29]Takagi K,Yamamori H,Morishima Y,et al.Preoperative immu-nosuppression:its relationship with high morbidity and mortality inpatients receiving thoracic esophagectomy[J].Nutrition,2001,17(1):13-17.

[30]Druml W.Nutritional management of acute renal failure[J].Am JKidney Dis,2001,37(Suppl 2):89-94.

[31]Braga M,Gianotti L,Vignali A,et al.Preoperative oral arginineand n-3 fatty acid supplementation improves the immunometabolichost response and outcome after colorectal resection for cancer[J].Surgery,2002,132(5):805-814.

[32]江华,蒋朱明,罗斌,等.免疫肠内营养用于临床营养支持的证据:中英文文献的系统评价[J].中国医学科学院学报,2002,24(6):552-558.

[33]Berger MM,Shenkin A.Vitamins and trace elements:practicalaspects of supplementation[J].Nutrition,2006,22(9):952-955.

[34]Lundholm K,Korner U,Gunnebo L,et a1.Insulin treatment incancer cachexia:effects on survival,metabolism,and physicalfunctioning[J].Clin Cancer Res,2007,13(9):2699-2706.

[35]Andreyev HJ,Norman AR,Oates J,et al.Why do patients withweight loss have a worse outcome when undergoing chemotherapyfor gastrointestinal malignancies?[J].Eur J Cancer,1998,34(4):503-509.

[36]Aslani A,Smith RC,Allen BJ,et al.The predictive value of bodyprotein for chemotherapy-induced toxicity[J].Cancer,2000,88(4):796-803.

[37]Bauer JD,Capra S.Nutrition intervention improves outcomes inpatients with cancer cachexia receiving chemotherapy—a pilot stud-y[J].Support Care Cancer,2005,13(4):270-274.

[38]Shang E,Weiss C,Post S,et al.The influence of early supple-mentation of parenteral nutrition on quality of life and body compo-sition in patients with advanced cancer[J].JPEN J Parenter En-teral Nutr,2006,30(3):222-230.

[39]Gramignano G,Lusso MR,Madeddu C,et al.Efficacy of l-carni-tine administration on fatigue,nutritional status,oxidative stress,and related quality of life in 12 advanced cancer patients undergo-ing anticancer therapy[J].Nutrition,2006,22(2):136-145.

[40]Hasenberg T,Essenbreis M,Herold A,et al.Early supplementa-tion of parenteral nutrition is capable of improving quality of life,chemotherapy-related toxicity and body composition in patients withadvanced colorectal carcinoma undergoing palliative treatment Re-sults from a prospective,randomized clinical trial[J].ColorectalDis,2010,12(10):190-199.

[41]McCarthy D,Weihofen D.The effect of nutritional supplements onfood intake in patients undergoing radiotherapy[J].Oncol NursForum,1999,26(5):897-900.

[42]Arnold C,Richter MP.The effect of oral nutritional supplementson head and neck cancer[J].Int J Radiat Oncol Biol Phys,1989,16(6):1595-1599.

[43]Elkort RJ,Baker FL,Vitale JJ,et al.Long-term nutritional sup-port as an adjunct to chemotherapy for breast cancer[J].JPEN JParenter Enteral Nutr,1981,5(5):385-390.

[44]De CM,Panarello G,Fantin D,et al.Parenteral nutrition incancer patients receiving chemotherapy:effects on toxicity and nu-tritional status[J].JPEN J Parenter Enteral Nutr,1993,17(6):513-518.

[45]Valdivieso M,Frankmann C,Murphy WK,et al.Long-termeffects of intravenous hyperalimentation administered during inten-sive chemotherapy for small cell bronchogenic carcinoma[J].Cancer,1987,59(2):362-369.

[46]Brard L,Weitzen S,Strubel-Lagan SL,et al.The effect of totalparenteral nutrition on the survival of terminally ill ovarian cancerpatients[J].Gynecol Oncol,2006,103(1):176-180.

[47]Jones L,Watling RM,Wilkins S,et al.Nutritional support inchildren and young people with cancer undergoing chemotherapy[J].Cochrane Database Syst Rev,2010,20(7):3298.

[48]Marten A,Wente MN,Ose J,et al.An open label randomizedmulticentre phaseⅢB trial comparing parenteral substitution versusbest supportive nutritional care in subjects with pancreatic adeno-carcinoma receiving 5-FU plus oxaliplatin as 2nd or higher linechemotherapy regarding clinical benefit-PANUSCO[J].BMCCancer,2009,9:412.

[49]Scolapio JS,Fleming CR,Kelly DG,et al.Survival of home par-enteral nutrition-treated patients:20 years of experience at theMayo Clinic[J].Mayo Clin Proc,1999,74(3):217-222.

[50]de Vries EG,Mulder NH,Houwen B,et al.Enteral nutrition bynasogastric tube in adult patients treated with intensive chemothera-py for acute leukemia[J].Am J Clin Nutr,1982,35(6):1490-1496.

[51]Koretz RL,Lipman TO,Klein S.AGA technical review on paren-teral nutrition[J].Gastroenterology,2001,121(4):970-1001.

[52]Fini L,Piazzi G,Ceccarelli C,et al.Highly purified eicosapen-taenoic acid as free fatty acids strongly suppresses polyps in Apc-Min/+mice[J].Clin Cancer Res,2010,16(23):5703-5711.

[53]Schley PD,Jijon HB,Robinson LE,et al.Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 humanbreast cancer cells[J].Breast Cancer Res Treat,2005,92(2):187-195.

[54]Dewey A,Baughan C,Dean TP,et al.Eicosapentaenoic acid(EPA,an omega-3 fatty acid from fish oils)for the treatment ofcancer cachexia[J].Cochrane Database Syst Rev,2007,1:4597.

[55]Jatoi A,Rowland K,Loprinzi CL,et al.An eicosapentaenoic acidsupplement versus megestrol acetate versus both for patients withcancer-associated wasting:a North Central Cancer Treatment Groupand National Cancer Institute of Canada collaborative effort[J].JClin Oncol,2004,22(12):2469-2476.

[56]Szymanski KM,Wheeler DC,Mucci LA.Fish consumption andprostate cancer risk:a review and meta-analysis[J].Am J ClinNutr,2010,92(5):1223-1233.

[57]Gogos CA,Ginopoulos P,Salsa B,et al.Dietary omega-3polyun-saturated fatty acids plus vitamin E restore immunodeficiency andprolong survival for severely ill patients with generalized malignan-cy:a randomized control trial[J].Cancer,1998,82(2):395-402.

[58]Xue H,Le RS,Sawyer MB,et al.Single and combined supple-mentation of glutamine and n-3 polyunsaturated fatty acids on hosttolerance and tumour response to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy camptothecin(CPT-11)/5-fluorouracilchemotherapy in rats bearing Ward colon tumour[J].Br J Nutr,2009,102(3):434-442.

[59]Ng K,Meyerhardt JA,Chan JA,et al.Multivitamin use is not as-sociated with cancer recurrence or survival in patients with stage IIIcolon cancer:findings from CALGB 89803[J].J Clin Oncol,2010,28(28):4354-4363.

[60]Polisena CG,Wade VR.Cancer patients need referrals to dieti-tians[J].J Am Diet Assoc,1993,93(9):975-976.

[61]Daly JM,Weintraub FN,Shou J,et al.Enteral nutrition duringmultimodality therapy in upper gastro-intestinal cancer patients[J].Ann Surg,1995,221(4):327-338.

[62]Fietkau R,Iro H,Sailer D,et al.Percutaneous endoscopicallyguided gastrostomy in patients with head and neck cancer[J].RecRes Cancer Res,1991,121:269-282.

[63]Thiel HJ,Fietkau R,Sauer R.Malnutrition and the role of nutri-tional support for radiation therapy patients[J].Rec Res CancerRes,1988,108:205-226.

[64]Langius JA,Doornaert P,Spreeuwenberg MD,et al.Radiotherapyon the neck nodes predicts severe weight loss in patients with earlystage laryngeal cancer[J].Radiother Oncol,2010,97(1):80-85.

[65]Collins MM,Wight RG,Partridge G.Nutritional conse-quences ofradiotherapy in early laryngeal carcinoma[J].Ann Royal CollSurg,1999,81(6):376-381.

[66]Isenring EA,Capra S,Bauer JD.Nutrition intervention is benefi-cial in oncology outpatients receiving radiotherapy to the gastroin-testinal or head and neck area[J].Br J Cancer,2004,91(3):447-452.

[67]van den Berg MG,Rasmussen-Conrad EL,Wei KH,et al.Com-parison of the effect of individual dietary counselling and of stand-ard nutritional care on weight loss in patients with head and neckcancer undergoing radiotherapy[J].Br J Nutr,2010,104(6):872-877.

[68]Ravasco P,Monteiro-Grillo I,Vidal PM,et al.Dietary counselingimproves patient outcomes:a prospective,randomized,controlledtrial in colorectal cancer patients undergoing radiotherapy[J].JClin Oncol,2005,23(7):1431-1438.

[69]Lee JH,Machtay M,Unger LD,et al.Prophylactic gastrostomytubes in patients undergoing intensive irradiation for cancer of thehead and neck[J].Arch Otolaryngol Head Neck Surg,1998,124(8):871-875.

[70]Marcy PY,Magne N,Bensadoun RJ,et al.Systematic percutane-ous fluoroscopic gastrostomy for concomitant radiochemotherapy ofadvanced head and neck cancer:optimization of therapy[J].SuppCare Cancer,2000,8(5):410-413.

[71]Tyldesley S,Sheehan F,Munk P,et al.The use of radiologicallyplaced gastrostomy tubes in head and neck cancer patients receivingradiotherapy[J].Int J Radiat Oncol Biol Phys,1996,36(5):1205-1209.

[72]Beer KT,Krause KB,Zuercher T,et al.Early percutaneous endo-scopic gastrostomy insertion maintains nutritional state in patientswith aerodigestive tract cancer[J].Nutr Cancer,2005,52(1):29-34.

[73]Mangar S,Slevin N,Mais K,et al.Evaluating predictive factorsfor determining enteral nutrition in patients receiving radical radio-therapy for head and neck cancer:a retrospective review[J].Ra-diother Oncol,2006,78(2):152-158.

[74]Rabinovitch R,Grant B,Berkey BA,et al.Impact of nutritionsupport on treatment outcome in patients with locally advancedhead and neck squamous cell cancer treated with definitive radio-therapy:a secondary analysis of RTOG trial 90-03[J].HeadNeck,2006,28(4):287-296.

[75]Scolapio JS,Tarrosa VB,Stoner GL,et al.Audit of nutrition sup-port for hematopoietic stem cell transplantation at a single institu-tion[J].Mayo Clin Proc,2002,77(7):654-659.

[76]Paccagnella A,Morello M,Da Mosto MC,et al.Early nutritionalintervention improves treatment tolerance and outcomes in head andneck cancer patients undergoing concurrent chemoradiotherapy[J].Support Care Cancer,2010,18(7):837-845.

[77]Freedman B.Equipose and the ethics of clinical research[J].NEngl J Med,1987,317(3):141-145.

[78]Loiudice TA,Lang JA.Treatment of radiation enteritis:a compari-son study[J].Am J Gastroenterol,1983,78(8):481-487.

[79]Bozzetti F,Staun M,van Gossum A.Home parenteral nutrition[M].Oxon:CAB International Publ,2006:95-102.

[80]Strang P.The effect of megestrol acetate on anorexia,weight lossand cachexia in cancer and AIDS patients[J].Anticancer Res,1997,17(1B):657-662.

[81]Lundholm K,Daneryd P,Bosaeus I,et al.Palliative nutritional in-tervention in addition to cyclooxygenase and erythropoietin treat-ment for patientswith malignant disease:effects on survival,metab-olism,and function[J].Cancer,2004,100(9):1967-1977.

[82]黎介寿.重症患者营养治疗个体化的思考[J].肠外与肠内营养,2009,16(4):193-194.

[83]Huhmann MB,August DA.Review of American Society for Paren-teral and Enteral Nutrition(ASPEN)clinical guidelines for nutri-tion support in cancer patients:nutrition screening and assessment[J].Nutr Clin Pract,2008,23(2):182-188.

[84]Ruiz-Garcia V,Juan O,Perez Hoyos S,et al.Megestrol acetate:a systematic review usefulness about the weight gain in neoplasticpatientswith cachexia[J].Med Clin(Barc),2002,119(5):166-170.

[85]Babcock T,Helton WS,Espat NJ.Eicosapentaenoic acid(EPA):an antiinflammatory omega-3 fat with potential clinical ap-plications[J].Nutrition,2000,16(11-12):1116-1118.

[86]高佳琦,吴国豪,袁磊,等.ω-3多不饱和脂肪酸对改善荷瘤大鼠营养状况的作用[J].外科理论与实践,2008,13(5):419-422.

[87]Fetteri NR,Metuffic JC,Carroll MA,et al.Renal cox-2cytokinesand 20-hete:tubular and vascularmechanisms[J].Curr Parm De-sign,2004,10(6):613-626.

[88]Gordon JN,Trebble TM,Ellis RD,et al.Thalidomide in thetreatment of cancer cachexia:a randomised placebo controlled trial[J].Gut,2005,54(4):540-545.

[89]MacDonald N,Easson AM,Mazurak VC,et al.Understandingand managing cancer cachexia[J].J Am Coll Surg,2003,197(1):143-161.